BackXenetic Biosciences- Warrants (19/07/2024) Overview

Xenetic Biosciences- Warrants (19/07/2024) Current Assets

Xenetic Biosciences- Warrants (19/07/2024)'s current assets is $7.6M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$7.60M
38.66% YoYΔ $2.12M vs prior year quarter

Peer average

Loading

Xenetic Biosciences- Warrants (19/07/2024) Current Assets History

Loading

Xenetic Biosciences- Warrants (19/07/2024) vs. peers: Current Assets Comparison

Loading

Xenetic Biosciences- Warrants (19/07/2024) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Xenetic Biosciences- Warrants (19/07/2024) (XBIOW) FAQ

As of the most recent data (March 2026), XBIOW shows a current assets of $7.6M. That compares with $5.5M in the prior-year period — up 38.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XBIOW's current assets is now $7.6M (was $5.5M) — a 38.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xenetic Biosciences- Warrants (19/07/2024) is outperforming or lagging.

Tracking XBIOW's current assets over time shows whether Xenetic Biosciences- Warrants (19/07/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $7.6M That compares with $5.5M in the prior-year period — up 38.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Xenetic Biosciences- Warrants (19/07/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $7.6M) with ownership activity and broader fundamentals.

Xenetic Biosciences- Warrants (19/07/2024)'s current assets is $7.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.